Who is sponsoring NCT05944380?

NCT05944380 is sponsored by Poznan University of Medical Sciences.

What drugs are being tested in NCT05944380?

Interventions in NCT05944380: Ropivacaine 0.5% Injectable Solution, 0,9% normal saline.

What condition does NCT05944380 study?

NCT05944380 studies Hip Osteoarthritis, Hip Arthropathy, Hip Disease, Hip Pain Chronic.

Is NCT05944380 still recruiting?

NCT05944380 is currently completed. Last updated 13 July 2023.

Last reviewed 2023-07-13 · How we verify

NCT05944380

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

PENG Block for Total Hip Arthroplasty

Completed Phase 4 Last updated 13 July 2023

What this trial tests

Phase 4 trial testing Ropivacaine 0.5% Injectable Solution in Hip Osteoarthritis in 556 participants. Completed in 30 January 2023.

Timeline

16 June 2020

Primary endpoint
23 June 2022

30 January 2023

Quick facts

Lead sponsor	Poznan University of Medical Sciences
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	556
Start date	16 June 2020
Primary completion	23 June 2022
Estimated completion	30 January 2023
Sites	1 location across Poland

Drugs / interventions tested

Ropivacaine 0.5% Injectable Solution — full drug profile →
0,9% normal saline — full drug profile →

Conditions studied

Hip Osteoarthritis — all drugs for Hip Osteoarthritis →
Hip Arthropathy — all drugs for Hip Arthropathy →
Hip Disease — all drugs for Hip Disease →
Hip Pain Chronic — all drugs for Hip Pain Chronic →

Sponsor

Poznan University of Medical Sciences

Who can join

Adults 18 to 100, any sex, with Hip Osteoarthritis or Hip Arthropathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized, double-blinded, placebo-controlled trial seeks to evaluate the efficacy of the pericapsular nerve group block on postoperative rehabilitation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Pain Management and Functional Recovery after Pericapsular Nerve Group (PENG) Block for Total Hip Arthroplasty: A Prospective, Randomized, Double-Blinded Clinical Trial.
Domagalska M, Ciftci B, Reysner T, Reysner T, et al · · 2023 · cited 21× · PMID 37568331 · DOI 10.3390/jcm12154931

Verify or expand the search:

Other trials of Ropivacaine 0.5% Injectable Solution

Trials testing the same drug.

NCT07180979 — PENG vs L-ESPB With S-ESPB for Analgesia in Total Hip Arthroplasty · Phase 4 · not yet recruiting
NCT06379490 — Ultrasound-guided Infraclavicular Block With Lidocaine or Ropivacaine for Closed Reduction of Distal Radius Fractures · Phase 3 · completed
NCT06381622 — Combining Lidocaine and Ropivacaine for an Infraclavicular Brachial Plexus Nerve Block · Phase 3 · completed
NCT05767749 — Split Face Study of the Duration of Local Anesthetics · Phase 4 · completed
NCT05024344 — ESP Block vs Control for Pain Control Following Percutaneous Nephrolithotomy · NA · recruiting

Other recruiting trials for Hip Osteoarthritis

Currently open trials in the same condition.

NCT07330999 — Three Variants of the PENG Block With and Without Perineural Adjuvants in Older Adults · NA · recruiting
NCT07327931 — PENG Block Variants With Dexamethasone and Dexmedetomidine in Older Adults · NA · recruiting
NCT07288983 — PENG Block vs Suprainguinal FICB vs Lumbar ESPB for Analgesia After Hip Surgery · NA · recruiting
NCT07327372 — PENG Block With Dexmedetomidine in Older Adults · NA · recruiting
NCT07347041 — Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Hip Osteoarthritis(OA) · NA · recruiting

Other Poznan University of Medical Sciences trials

Trials by the same sponsor.

NCT07449468 — PENG Block and Delirium After Hip Arthroplasty · NA · not yet recruiting
NCT07449442 — SII Levels Following iPACK Block With Adductor Canal Block in Knee Arthroplasty · NA · not yet recruiting
NCT07474896 — Diaphragm-Sparing Regional Anesthesia Techniques for Shoulder Surgery · NA · not yet recruiting
NCT07474909 — Perineural vs Intravenous Dexamethasone as an Adjuvant to Brachial Plexus Block in Pediatric Hand Surgery · NA · not yet recruiting
NCT07449403 — SII Levels Following PENG Block in Hip Arthroplasty · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05944380 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Poznan University of Medical Sciences
Last refreshed: 13 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05944380.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing